AAAAAA
Results:
1-15
|
Results: 15
Authors:
van Bezooijen, RL
Papapoulos, SE
Lowik, CWGM
Citation: Rl. Van Bezooijen et al., Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: Is there dependency on nuclear factor-kappa B and receptor activator of nuclear factor kappa B (RANK)/RANK ligand signaling?, BONE, 28(4), 2001, pp. 378-386
Authors:
Versluis, RGJA
Papapoulos, SE
de Bock, GH
Zwinderman, AH
Petri, H
van de Ven, CM
Springer, MP
Citation: Rgja. Versluis et al., Clinical risk factors as predictors of postmenopausal osteoporosis in general practice, BR J GEN PR, 51(471), 2001, pp. 806-810
Authors:
Schell-Feith, EA
Que, L
Kok, DJ
Kist-van Holthe, JE
Kuhler, E
Brand, R
Papapoulos, SE
van der Heijden, BJ
Citation: Ea. Schell-feith et al., Modulation of calcium oxalate monohydrate crystallization kinetics by urine of preterm neonates, AM J KIDNEY, 38(6), 2001, pp. 1229-1234
Authors:
Hamdy, NAT
Papapoulos, SE
Citation: Nat. Hamdy et Se. Papapoulos, The palliative management of skeletal metastases in prostate cancer: Use of bone-seeking radionuclides and bisphosphonates, SEM NUC MED, 31(1), 2001, pp. 62-68
Authors:
Versluis, RGJA
Petri, H
Vismans, FJFE
de Ven, CMV
van de Ven, CM
Springer, MP
Papapoulos, SE
Citation: Rgja. Versluis et al., The relationship between phalangeal bone density and vertebral deformities, CALCIF TIS, 66(1), 2000, pp. 1-4
Authors:
Deckers, MML
Karperien, M
van der Bent, C
Yamashita, T
Papapoulos, SE
Lowik, CWGM
Citation: Mml. Deckers et al., Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation, ENDOCRINOL, 141(5), 2000, pp. 1667-1674
Authors:
Papapoulos, SE
Citation: Se. Papapoulos, Bisphosphonates in the treatment of osteoporosis - Principles and efficacy, ANN MED IN, 151(6), 2000, pp. 504-510
Authors:
Bravenboer, N
Papapoulos, SE
Holzmann, P
Hamdy, NAT
Netelenbos, JC
Lips, P
Citation: N. Bravenboer et al., Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis, OSTEOPOR IN, 9(6), 1999, pp. 489-493
Authors:
Versluis, RGJA
Petri, H
van de Ven, CM
Scholtes, ABJ
Broerse, ER
Springer, MP
Papapoulos, SE
Citation: Rgja. Versluis et al., Usefulness of armspan and height comparison in detecting vertebral deformities in women, OSTEOPOR IN, 9(2), 1999, pp. 129-133
Authors:
Karperien, M
Farih-Sips, H
Hendriks, JAA
Lanske, B
Papapoulos, SE
Abou-Samra, AB
Lowik, CWGM
Defize, LHK
Citation: M. Karperien et al., Identification of a retinoic acid-inducible element in the murine PTH PTHrP (parathyroid hormone parathyroid hormone-related peptide) receptor gene, MOL ENDOCR, 13(7), 1999, pp. 1183-1196
Authors:
Van Bezooijen, RL
Farih-Sips, HCM
Papapoulos, SE
Lowik, CWGM
Citation: Rl. Van Bezooijen et al., Interleukin-17: A new bone acting cytokine in vitro, J BONE MIN, 14(9), 1999, pp. 1513-1521
Authors:
Van Bezooijen, RL
Van der Bent, C
Papapoulos, SE
Lowik, CWGM
Citation: Rl. Van Bezooijen et al., Oestrogenic compounds modulate cytokine-induced nitric oxide production inmouse osteoblast-like cells, J PHARM PHA, 51(12), 1999, pp. 1409-1414
Authors:
Karperien, M
van der Harten, HJ
van Schooten, R
Farih-Sips, H
den Hollander, NS
Kneppers, SLJ
Nijweide, P
Papapoulos, SE
Lowik, CWGM
Citation: M. Karperien et al., A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-relatedpeptide receptor causing blomstrand lethal osteochondrodysplasia, J CLIN END, 84(10), 1999, pp. 3713-3720
Authors:
Compston, JE
Papapoulos, SE
Blanchard, F
Citation: Je. Compston et al., Report on osteoporosis in the European community: Current status and recommendations for the future, OSTEOPOR IN, 8(6), 1998, pp. 531-534
Authors:
Smeets-Goevaers, CG
Lesusink, GL
Papapoulos, SE
Maartens, LW
Keyzer, JJ
Weerdenburg, JP
Beijers, LH
Zwinderman, AH
Knottnerus, JA
Pols, HA
Pop, VJ
Citation: Cg. Smeets-goevaers et al., The prevalence of low bone mineral density in Dutch perimenopausal women: The Eindhoven Perimenopausal Osteoporosis Study, OSTEOPOR IN, 8(5), 1998, pp. 404-409
Risultati:
1-15
|